Circulating free DNA

Dec 03, 2018

Congruence Study Between Two ctDNA Liquid Biopsy Testing in mBC Patients and Prognostic Value in Combination with CTCs, Investigators to Report at SABCS 2018

Oct 19, 2018

Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting

Sep 13, 2018

Natera Signs Agreement with Bristol-Myers Squibb to Investigate Signatera(TM) ctDNA Assay as a Potential Biomarker for Opdivo (nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clinical Trial

Aug 28, 2018

Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident, Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing

Aug 03, 2018

Breast Cancer Liquid Biopsy Market Worth $411.1 Million by 2022

Nov 15, 2017

World Cancer Liquid Biopsy Market 2017 - Insufficient Demonstrated Clinical Utility to Slow Adoption by Oncologists

Nov 15, 2017

New Report Projects "Realistic" $1.3 Billion Dollar Liquid Biopsy Market by 2021